Mechanisms of lung fibrosis induced by carbon nanotubes: towards an Adverse Outcome Pathway (AOP)
about
sameAs
Evaluating the mechanistic evidence and key data gaps in assessing the potential carcinogenicity of carbon nanotubes and nanofibers in humansMyofibroblasts and lung fibrosis induced by carbon nanotube exposureToxicological Profiling of Highly Purified Metallic and Semiconducting Single-Walled Carbon Nanotubes in the Rodent Lung and E. coliLung fibrosisMulti-walled carbon nanotube-physicochemical properties predict the systemic acute phase response following pulmonary exposure in mice.A comprehensive framework for evaluating the environmental health and safety implications of engineered nanomaterials.The Genetic Heterogeneity among Different Mouse Strains Impacts the Lung Injury Potential of Multiwalled Carbon Nanotubes.T lymphocytes dominate local leukocyte infiltration in response to intradermal injection of functionalized graphene-based nanomaterial.Acute Nanoparticle Exposure to Vocal Folds: A Laboratory Study.Predicting pulmonary fibrosis in humans after exposure to multi-walled carbon nanotubes (MWCNTs).Stat-6 signaling pathway and not Interleukin-1 mediates multi-walled carbon nanotube-induced lung fibrosis in mice: insights from an adverse outcome pathway framework.Pine bark extract (Pycnogenol®) suppresses cigarette smoke-induced fibrotic response via transforming growth factor-β1/Smad family member 2/3 signaling.Mechanisms of carbon nanotube-induced pulmonary fibrosis: a physicochemical characteristic perspective.Mediation of the single-walled carbon nanotubes induced pulmonary fibrogenic response by osteopontin and TGF-β1.Cellular proliferation and differentiation induced by single-layer molybdenum disulfide and mediation mechanisms of proteins via the Akt-mTOR-p70S6K signaling pathway.Dioscin Exerts Protective Effects Against Crystalline Silica-induced Pulmonary Fibrosis in Mice.Nanomaterials: certain aspects of application, risk assessment and risk communication.Acute in vitro and in vivo toxicity of a commercial grade boron nitride nanotube mixture.Macrophage Recognition of Crystals and Nanoparticles.Macrophage polarization and activation at the interface of multi-walled carbon nanotube-induced pulmonary inflammation and fibrosis.Type 2 Immune Mechanisms in Carbon Nanotube-Induced Lung Fibrosis.The Toxic Truth About Carbon Nanotubes in Water Purification: a Perspective View.4-1BB Signaling Promotes Alveolar Macrophages-Mediated Pro-Fibrotic Responses and Crystalline Silica-Induced Pulmonary Fibrosis in Mice
P2860
Q27908506-D5EE2A62-A8C2-4840-8BCD-1D9446C4D282Q27969008-DA6B28EF-57D4-4875-B01B-95D53B02EEC7Q28383926-7B133354-6C4F-42CE-9293-9CE0AF990933Q30225397-0C6851DD-861B-48B4-9FCE-64AB730EF616Q36336029-DF28AD38-24D1-4340-8853-825FE27E3DEEQ38665194-793E6E90-28A4-43D7-9459-AC9F914FD4FDQ38693288-23C045C7-1D5C-405D-87E8-DE75A1FAF5D3Q38722659-A0A026D8-9194-49AB-AAF3-54D59166492DQ38822233-736A3226-AE3D-443D-A2D4-43DC8F513AD6Q38842130-236A9E3C-09E0-4F73-8E3D-C46169141CFDQ41107325-283D76EA-1737-4F4A-B1B8-24DB2D725314Q41126008-1C71646C-EA41-4FA7-83DB-DBBDA308B3E6Q44876003-68553ADC-AB07-4524-B6B2-3D461E97758CQ45072999-1914AC50-7DA1-4923-B71B-C2316B581B5FQ46334945-1F2A2BB5-18C9-4B5E-97F6-A56D7176C66CQ47135902-AB0C987C-9F31-4876-A2D8-AC7FC8CDECDBQ47222952-02337B92-9481-4512-8E85-5DE9E9CBD92EQ47450519-4BA65820-62DD-40B7-A5FB-64B242B79012Q50054487-28A6BB48-B960-4491-B910-906762BB4B71Q50102954-CA49F370-27EF-46D8-9519-151826FBEE51Q55241957-982A3AF0-107D-44B3-8326-54967949CD65Q55479748-479E546C-A27F-4EEF-9796-7AB336D19AC7Q58754498-94E823C5-B2CB-4990-AB3A-271137D8CBE7
P2860
Mechanisms of lung fibrosis induced by carbon nanotubes: towards an Adverse Outcome Pathway (AOP)
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Mechanisms of lung fibrosis in ...... Adverse Outcome Pathway (AOP)
@ast
Mechanisms of lung fibrosis in ...... Adverse Outcome Pathway (AOP)
@en
Mechanisms of lung fibrosis in ...... Adverse Outcome Pathway (AOP)
@nl
type
label
Mechanisms of lung fibrosis in ...... Adverse Outcome Pathway (AOP)
@ast
Mechanisms of lung fibrosis in ...... Adverse Outcome Pathway (AOP)
@en
Mechanisms of lung fibrosis in ...... Adverse Outcome Pathway (AOP)
@nl
prefLabel
Mechanisms of lung fibrosis in ...... Adverse Outcome Pathway (AOP)
@ast
Mechanisms of lung fibrosis in ...... Adverse Outcome Pathway (AOP)
@en
Mechanisms of lung fibrosis in ...... Adverse Outcome Pathway (AOP)
@nl
P2860
P921
P3181
P1476
Mechanisms of lung fibrosis in ...... Adverse Outcome Pathway (AOP)
@en
P2093
Giulia Vietti
Sybille van den Brule
P2860
P2888
P3181
P356
10.1186/S12989-016-0123-Y
P407
P5008
P577
2016-02-29T00:00:00Z
P5875
P6179
1029826884